Myeloid cells in Alzheimer’s disease: culprits, victims or innocent bystanders?
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increasing evidence supports the hypothesis that the microglial response to AD lesions controls disease progression”
From TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease (2017) · cites this paper as Meyer-Luehmann and Prinz, 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997
Naj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
Monocytes and macrophages: developmental pathways and tissue homeostasis
Ginhoux, F., & Jung, S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3671 · Cited by 1,840
Research works printed but not linked: 46
- Geissmann, 2010, Unravelling mononuclear phagocyte heterogeneity, Nat. Rev. Immunol., 10, 453, 10.1038/nri2784 · DOI · Paper page
- Yona, 2013, Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis, Immunity, 38, 79, 10.1016/j.immuni.2012.12.001 · DOI · Paper page
- Ginhoux, 2010, Fate mapping analysis reveals that adult microglia derive from primitive macrophages, Science, 330, 841, 10.1126/science.1194637 · DOI · Paper page
- Schulz, 2012, A lineage of myeloid cells independent of Myb and hematopoietic stem cells, Science, 336, 86, 10.1126/science.1219179 · DOI · Paper page
- Hagan, 2015, The molecular, cellular, and morphological components of blood-brain barrier development during embryogenesis, Semin. Cell Dev. Biol., 38, 7, 10.1016/j.semcdb.2014.12.006 · DOI
- Biber, 2015, CNS myeloid cells as drug targets: current status and translational challenges, Nat. Rev. Drug Discov.
- Hanisch, 2007, Microglia: active sensor and versatile effector cells in the normal and pathologic brain, Nat. Neurosci., 10, 1387, 10.1038/nn1997 · DOI · Paper page
- Jung, 2000, Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion, Mol. Cell. Biol., 20, 4106, 10.1128/MCB.20.11.4106-4114.2000 · DOI · Paper page
- Nimmerjahn, 2005, Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo, Science, 308, 1314, 10.1126/science.1110647 · DOI · Paper page
- Davalos, 2005, ATP mediates rapid microglial response to local brain injury in vivo, Nat. Neurosci., 8, 752, 10.1038/nn1472 · DOI · Paper page
- Erny, 2015, Host microbiota constantly control maturation and function of microglia in the CNS, Nat. Neurosci., 18, 965, 10.1038/nn.4030 · DOI · Paper page
- McMahon, 2006, CNS dendritic cells: critical participants in CNS inflammation?, Neurochem. Int., 49, 195, 10.1016/j.neuint.2006.04.004 · DOI
- D’Agostino, 2012, Brain dendritic cells: biology and pathology, Acta Neuropathol., 124, 599, 10.1007/s00401-012-1018-0 · DOI · Paper page
- Barkauskas, 2013, Extravascular CX3CR1+ cells extend intravascular dendritic processes into intact central nervous system vessel lumen, Microsc. Microanal., 19, 778, 10.1017/S1431927613000482 · DOI · Paper page
- Haass, 2004, Take five – BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation, EMBO J., 23, 483, 10.1038/sj.emboj.7600061 · DOI · Paper page
- Haass, 2007, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide, Nat. Rev. Mol. Cell Biol., 8, 101, 10.1038/nrm2101 · DOI · Paper page
- Yan, 2006, Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity, J. Mol. Biol., 364, 853, 10.1016/j.jmb.2006.09.046 · DOI · Paper page
- Frautschy, 1998, Microglial response to amyloid plaques in APPsw transgenic mice, Am. J. Pathol., 152, 307
- Paresce, 1997, Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells, J. Biol. Chem., 272, 29390, 10.1074/jbc.272.46.29390 · DOI · Paper page
- Majumdar, 2008, Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages, Neurobiol. Aging, 29, 707, 10.1016/j.neurobiolaging.2006.12.001 · DOI
- Wisniewski, 1991, Phagocytosis of beta/A4 amyloid fibrils of the neuritic neocortical plaques, Acta Neuropathol., 81, 588, 10.1007/BF00310142 · DOI
- Akiyama, 1996, The amino-terminally truncated forms of amyloid beta-protein in brain macrophages in the ischemic lesions of Alzheimer's disease patients, Neurosci. Lett., 219, 115, 10.1016/S0304-3940(96)13197-9 · DOI
- Brawek, 2014, Impairment of in vivo calcium signaling in amyloid plaque-associated microglia, Acta Neuropathol., 127, 495, 10.1007/s00401-013-1242-2 · DOI
- Wilcock, 2001, Number of Abeta inoculations in APP+PS1 transgenic mice influences antibody titers, microglial activation, and congophilic plaque levels, DNA Cell Biol., 20, 731, 10.1089/10445490152717596 · DOI · Paper page
- Wilcock, 2004, Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition, J. Neurosci., 24, 6144, 10.1523/JNEUROSCI.1090-04.2004 · DOI · Paper page
- Noda, 2011, Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression, J. Biol. Chem., 286, 2308, 10.1074/jbc.M110.169839 · DOI · Paper page
- Ye, 2015, Progression of seed-induced Abeta deposition within the limbic connectome, Brain Pathol., 10.1111/bpa.12252 · DOI · Paper page
- Guerreiro, 2013, TREM2 variants in Alzheimer's disease, N. Engl. J. Med., 368, 117, 10.1056/NEJMoa1211851 · DOI · Paper page
- Patel, 2005, Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease, J. Neuroinflammation, 2, 9, 10.1186/1742-2094-2-9 · DOI · Paper page
- Lue, 2001, Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro, Glia, 35, 72, 10.1002/glia.1072 · DOI · Paper page
- Cacabelos, 1991, Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders, Methods Find. Exp. Clin. Pharmacol., 13, 455
- Tachida, 2008, Interleukin-1 beta up-regulates TACE to enhance alpha-cleavage of APP in neurons: resulting decrease in Abeta production, J. Neurochem., 104, 1387, 10.1111/j.1471-4159.2007.05127.x · DOI · Paper page
- Akiyama, 2000, Inflammation and Alzheimer's disease, Neurobiol. Aging, 21, 383, 10.1016/S0197-4580(00)00124-X · DOI · Paper page
- Alafuzoff, 1983, Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia, J. Neurol. Sci., 60, 465, 10.1016/0022-510X(83)90157-0 · DOI
- Elovaara, 1985, CSF in Alzheimer's disease. Studies on blood–brain barrier function and intrathecal protein synthesis, J. Neurol. Sci., 70, 73, 10.1016/0022-510X(85)90189-3 · DOI
- Hampel, 1997, Blood-cerebrospinal fluid barrier dysfunction for high molecular weight proteins in Alzheimer disease and major depression: indication for disease subsets, Alzheimer Dis. Assoc. Disord., 11, 78, 10.1097/00002093-199706000-00004 · DOI · Paper page
- Skoog, 1998, A population study on blood–brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia, Neurology, 50, 966, 10.1212/WNL.50.4.966 · DOI · Paper page
- Blennow, 1990, Blood–brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors, Acta Neurol. Scand., 81, 323, 10.1111/j.1600-0404.1990.tb01563.x · DOI · Paper page
- Caserta, 1998, Blood–brain barrier integrity in Alzheimer's disease patients and elderly control subjects, J. Neuropsychiatry Clin. Neurosci., 10, 78, 10.1176/jnp.10.1.78 · DOI · Paper page
- Dysken, 1990, Rapid dynamic CT scanning in primary degenerative dementia and age-matched controls, Biol. Psychiatry, 28, 425, 10.1016/0006-3223(90)90410-4 · DOI
- Schlageter, 1987, Examination of blood–brain barrier permeability in dementia of the Alzheimer type with [68Ga]EDTA and positron emission tomography, J. Cereb. Blood Flow Metab., 7, 1, 10.1038/jcbfm.1987.1 · DOI · Paper page
- Bronge, 2000, White matter lesions in dementia: an MRI study on blood–brain barrier dysfunction, Dement. Geriatr. Cogn. Disord., 11, 263, 10.1159/000017248 · DOI · Paper page
- Kumar-Singh, 2005, Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls, Am. J. Pathol., 167, 527, 10.1016/S0002-9440(10)62995-1 · DOI · Paper page
- Stalder, 2005, Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice, J. Neurosci., 25, 11125, 10.1523/JNEUROSCI.2545-05.2005 · DOI · Paper page
- Lebson, 2010, Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic mice, J. Neurosci., 30, 9651, 10.1523/JNEUROSCI.0329-10.2010 · DOI · Paper page
- Simard, 2006, Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease, Neuron, 49, 489, 10.1016/j.neuron.2006.01.022 · DOI · Paper page
Cited by
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease
Ulland, T. K., Song, W. M., Huang, S. C.-C., Ulrich, J. D., Sergushichev, A., Beatty, W. L., Loboda, A. A., Zhou, Y., Cairns, N. J., Kambal, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.023 · Cited by 1,263
The role of peripheral immune cells in the CNS in steady state and disease
Prinz, M., & Priller, J. (2017) · Nature Neuroscience · doi:10.1038/nn.4475 · Cited by 657
Self-citationErny, D., Dokalis, N., Mezö, C., Castoldi, A., Mossad, O., Staszewski, O., Frosch, M., Villa, M., Fuchs, V., Mayer, A., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.10.010 · Cited by 478
Self-citationThe role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.
Ramirez, A. I., de Hoz, R., Salobrar-Garcia, E., Salazar, J. J., Rojas, B., Ajoy, D., López-Cuenca, I., Rojas, P., Triviño, A., & Ramírez, J. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00214 · Cited by 466
“Missense mutations in TREM2 lead to a significant risk of developing AD (Jonsson et al., 2013; Meyer-Luehmann and Prinz, 2015).”
BackgroundTREM2 variants: new keys to decipher Alzheimer disease pathogenesis
Colonna, M., & Wang, Y. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.7 · Cited by 418
Metadata
- Authors
- Meyer-Luehmann, M., & Prinz, M.
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 38
- Issue
- 10
- Pages
- 659-668
- ISSN
- 0166-2236
- Cited by
- 55
- References
- 68
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Myeloid cells in Alzheimer’s disease: culprits, victims or innocent bystanders? https://app.cochat.ai/papers/10.1016/j.tins.2015.08.011
- The paper
- Meyer-Luehmann, M., & Prinz, M. (2015). Myeloid cells in Alzheimer’s disease: culprits, victims or innocent bystanders? Trends in Neurosciences. https://doi.org/10.1016/j.tins.2015.08.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.